Wenliang Chen | Clinical medicine | Best Researcher Award

Assoc. Prof. Dr. Wenliang Chen | Clinical medicine | Best Researcher Award

Assoc. Prof. Dr. Wenliang Chen, Shanxi Medical University, China

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Masterโ€™s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Publication Profile

Orcid

Education ๐ŸŽ“

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Masterโ€™s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Experience ๐Ÿ’ผ

Dr. Chenโ€™s career spans more than 20 years, beginning as a General Surgeon at the Second Hospital of Shanxi Medical University. His experience includes advanced surgical training at Beijing Chaoyang Hospital and Peking University People’s Hospital. Additionally, he gained international insights as a Visiting Scholar at Duke University Medical Center and The Ohio State University. Since 2015, he has been a prominent figure in gastrointestinal and minimally invasive surgeries. His dedication to patient care and academic mentorship has greatly contributed to the institutionโ€™s medical excellence.

Awards and Honors ๐Ÿ†

Assoc. Prof. Dr. Wenliang Chen has earned numerous accolades for his contributions to the field of surgery. His pioneering efforts in obesity and diabetes surgery in Shanxi Province and his successful laparoscopic Nissen fundoplication for gastroesophageal reflux disease have established him as a surgical innovator. Furthermore, his active roles in national and provincial medical committees, including the Colorectal Cancer Committee and the Gastrointestinal Surgery Committee, exemplify his leadership and dedication to medical advancement.

Research Focus ๐Ÿ”Ž

Dr. Chen’s research primarily focuses on the diagnosis and surgical treatment of gastrointestinal diseases. He has led significant studies, notably as Principal Investigator on the regulatory mechanism of LncRNA PVT1 in gastric cancer proliferation and invasion. His interest in minimally invasive surgeries has led to advancements in laparoscopic techniques, benefiting patient recovery and surgical outcomes. His dedication to translational research has strengthened the clinical application of innovative treatments, contributing to the advancement of gastrointestinal oncology and metabolic disease management.

Publication Top Notes

๐Ÿ“„ Innovative Approaches to Managing Postoperative Complications in Laparoscopic Sleeve Gastrectomy: A Scoping Review (2024) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A | ๐Ÿ”— DOI: 10.1089/lap.2024.0227

๐Ÿ“„ Oxidative stress-related patterns determination for establishment of prognostic models, and characteristics of tumor microenvironment infiltration (2022) | ๐Ÿ› Frontiers in Surgery | ๐Ÿ”— DOI: 10.3389/fsurg.2022.1013794

๐Ÿ“„ Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer (2022) | ๐Ÿ› Frontiers in Immunology | ๐Ÿ”— DOI: 10.3389/fimmu.2022.962056

๐Ÿ“„ Efficacy and safety of over-the-scope clips for colorectal leaks and fistulas: a pooled analysis (2022) | ๐Ÿ› Minimally Invasive Therapy & Allied Technologies | ๐Ÿ”— DOI: 10.1080/13645706.2021.2010218

๐Ÿ“„ LncRNA SNHG6 inhibits autophagy of gastric carcinoma cells via PI3K/AKT/mTOR signaling pathway (2022) | ๐Ÿ› American Journal of Translational Research | ๐Ÿ”— PMID: 35702105

๐Ÿ“„ The Role of lncRNA PVT1 and hsa-miR-30a-3p in the Development of Gastric Cancer (2022) | ๐Ÿ› Annals of Clinical and Laboratory Science | ๐Ÿ”— PMID: 35414508

๐Ÿ“„ Laparoscopy for Hepatolithiasis: Biliary Duct Exploration with Primary Closure Versus T-Tube Drainage (2020) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques | ๐Ÿ”— DOI: 10.1089/lap.2020.0081

๐Ÿ“„ A Comparison of the Relative Safety and Efficacy of Laparoscopic Choledochotomy with Primary Closure and Endoscopic Treatment for Bile Duct Stones in Patients with Cholelithiasis (2020) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques | ๐Ÿ”— DOI: 10.1089/lap.2019.0775

 

Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikashย  Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes ๐Ÿ“š

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11โ€“16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315โ€“324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barrรฉ syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852โ€“854

Citations:

 

 

 

 

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidisโ€™s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. ๐Ÿฉบ๐Ÿ’‰๐Ÿ”ฌ

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission โ€ 

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease